{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:38:29Z","timestamp":1776371909781,"version":"3.51.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-022-01849-6","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T04:02:32Z","timestamp":1660881752000},"page":"3067-3081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6931-4399","authenticated-orcid":false,"given":"Lasse Rehn\u00e9","family":"Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5930-0636","authenticated-orcid":false,"given":"Andrea Daniela","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atle","family":"Lomstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-8181","authenticated-orcid":false,"given":"Thomas","family":"Graillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Hrachova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9680-9060","authenticated-orcid":false,"given":"Daniela","family":"Bota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1274-9273","authenticated-orcid":false,"given":"Alejandro","family":"Ruiz-Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-3779","authenticated-orcid":false,"given":"Oscar","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-3514","authenticated-orcid":false,"given":"Andr\u00e9s Felipe","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9134-1537","authenticated-orcid":false,"given":"Roberta","family":"Rud\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-3681","authenticated-orcid":false,"given":"Julia","family":"Furtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Roeckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-2315","authenticated-orcid":false,"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-1198","authenticated-orcid":false,"given":"David","family":"Scheie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle","family":"Broholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-0826","authenticated-orcid":false,"given":"Bjarne Winther","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8689-9704","authenticated-orcid":false,"given":"Jane","family":"Skj\u00f8th-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6611-3102","authenticated-orcid":false,"given":"Morten","family":"Ziebell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5938-000X","authenticated-orcid":false,"given":"Tina N\u00f8rgaard","family":"Munch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1520-7122","authenticated-orcid":false,"given":"K\u00e5re","family":"Fugleholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6487-5349","authenticated-orcid":false,"given":"Martin A.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9463-1919","authenticated-orcid":false,"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6801-0123","authenticated-orcid":false,"given":"Christian","family":"Mirian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"1849_CR1","doi-asserted-by":"publisher","DOI":"10.1023\/B:NEON.0000013498.19981.55","author":"S Arena","year":"2004","unstructured":"Arena S, Barbieri F, Thellung S, Pirani P, Corsaro A, Villa V, Dadati P, Dorcaratto A, Lapertosa G, Ravetti JL, Spaziante R, Schettini G, Florio T (2004) Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol. https:\/\/doi.org\/10.1023\/B:NEON.0000013498.19981.55","journal-title":"J Neurooncol"},{"key":"1849_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10143-021-01552-y","volume":"45","author":"F Behling","year":"2022","unstructured":"Behling F, Fodi C, Skardelly M et al (2022) Differences in the expression of SSTR1\u20135 in meningiomas and its therapeutic potential. Neurosurg Rev 45:467\u2013478. https:\/\/doi.org\/10.1007\/s10143-021-01552-y","journal-title":"Neurosurg Rev"},{"key":"1849_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-021-01552-y","author":"F Behling","year":"2021","unstructured":"Behling F, Fodi C, Skardelly M, Renovanz M, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J (2021) Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential. Neurosurg Rev. https:\/\/doi.org\/10.1007\/s10143-021-01552-y","journal-title":"Neurosurg Rev"},{"key":"1849_CR4","doi-asserted-by":"publisher","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, A Ducar M, Thorner AR, van Hummelen P, O Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R (2017) Erratum: genomic landscape of high-grade meningiomas. NPJ Genom Med 2:26. https:\/\/doi.org\/10.1038\/s41525-017-0014-7","DOI":"10.1038\/s41525-017-0014-7"},{"key":"1849_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0217340","volume":"14","author":"AF Cardona","year":"2019","unstructured":"Cardona AF, Ruiz-Pati\u00f1o A, Zatarain-Barr\u00f3n ZL, Hakim F, Jim\u00e9nez E, Mej\u00eda JA, Ram\u00f3n JF, Useche N, Berm\u00fadez S, Pineda D, Cifuentes H, Rojas L, Ricaurte L, Pino LE, Bala\u00f1a C, Arrieta O (2019) Systemic management of malignant meningiomas: a comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib. PLoS One 14:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0217340","journal-title":"PLoS One"},{"key":"1849_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1212\/01.wnl.0000271382.62776.b7","volume":"69","author":"M Chamberlain","year":"2007","unstructured":"Chamberlain M, Glantz MJ, Fadul CE (2007) Recurrent meningioma\u2014salvage therapy with long-acting somatostain analogue. Neurology 69:969\u2013973","journal-title":"Neurology"},{"key":"1849_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Av\u015far T, Li J, Murray PB, Henegariu O, Yilmaz S, G\u00fcnel JM, Carri\u00f3n-Grant G, Yilmaz B, Grady C, Tanrikulu B, Bakircio\u011flu M, Kaymak\u00e7alan H, Caglayan AO, Sencar L, Ceyhun E, Atik AF, Bayri Y, Bai H, Kolb LE, Hebert RM, Omay SB, Mishra-Gorur K, Choi M, Overton JD, Holland EC, Mane S, State MW, Bilg\u00fcvar K, Baehring JM, Gutin PH, Piepmeier JM, Vortmeyer A, Brennan CW, Pamir MN, Kili\u00e7 T, Lifton RP, Noonan JP, Yasuno K, G\u00fcnel M (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science"},{"key":"1849_CR8","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E03-02-0069","author":"G Ferjoux","year":"2003","unstructured":"Ferjoux G, Lopez F, Esteve JP, Ferrand A, Vivier E, Vely F, Saint-Laurent N, Pradayrol L, Buscail L, Susini C (2003) Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. Mol Biol Cell. https:\/\/doi.org\/10.1091\/mbc.E03-02-0069","journal-title":"Mol Biol Cell"},{"key":"1849_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mce.2007.08.012","volume":"286","author":"T Florio","year":"2008","unstructured":"Florio T (2008) Somatostatin\/somatostatin receptor signalling: phosphotyrosine phosphatases. Mol Cell Endocrinol 286:40\u201348. https:\/\/doi.org\/10.1016\/j.mce.2007.08.012","journal-title":"Mol Cell Endocrinol"},{"key":"1849_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/neuonc\/nov183","volume":"18","author":"J Furtner","year":"2016","unstructured":"Furtner J, Sch\u00f6pf V, Seystahl K, Le Rhun E, Rud\u00e0 R, Roelcke U, Koeppen S, Berghoff AS, Marosi C, Clement P, Faedi M, Watts C, Wick W, Soffietti R, Weller M, Preusser M, Seystahl K, Le RE, Ruda R, Scho V, Koeppen S, Berghoff AS, Marosi C, Clement P, Faedi M, Watts C, Wick W, Soffietti R, Weller M, Preusser M (2016) Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro Oncol 18:401\u2013407. https:\/\/doi.org\/10.1093\/neuonc\/nov183","journal-title":"Neuro Oncol"},{"key":"1849_CR11","unstructured":"Garc\u00eda-Luna, P.P., Relimpio, F., Pumar, A., Pereira, J.L., Leal-Cerro, A., Trujillo, F., Cortes, A., & Astorga, R. (1993). Clinical use of octreotide in unresectable meningiomas. A report of three cases.\u00a0J Neurol Sci 37(4):237\u201341"},{"key":"1849_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab150","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro Oncol"},{"key":"1849_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11060-015-1812-3","volume":"124","author":"T Graillon","year":"2015","unstructured":"Graillon T, Defilles C, Mohamed A, Lisbonis C, Germanetti AL, Chinot O, Figarella-Branger D, Roche PH, Adetchessi T, Fuentes S, Metellus P, Dufour H, Enjalbert A, Barlier A (2015) Combined treatment by octreotide and everolimus: octreotide enhances inhibitory effect of everolimus in aggressive meningiomas. J Neurooncol 124:33\u201343. https:\/\/doi.org\/10.1007\/s11060-015-1812-3","journal-title":"J Neurooncol"},{"key":"1849_CR14","doi-asserted-by":"publisher","first-page":"55361","DOI":"10.18632\/oncotarget.19517","volume":"8","author":"T Graillon","year":"2017","unstructured":"Graillon T, Romano D, Defilles C, Lisbonis C, Saveanu A, Figarella-Branger D, Roche P-H, Fuentes S, Chinot O, Dufour H, Barlier A (2017) Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma <i>in vitro<\/i>. Oncotarget 8:55361\u201355373. https:\/\/doi.org\/10.18632\/oncotarget.19517","journal-title":"Oncotarget"},{"key":"1849_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3171\/2016.8.JNS16995","volume":"127","author":"T Graillon","year":"2017","unstructured":"Graillon T, Romano D, Defilles C, Saveanu A, Mohamed A, Figarella-Branger D, Roche P-H, Fuentes S, Chinot O, Dufour H, Barlier A (2017) Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review. J Neurosurg 127:660\u2013669. https:\/\/doi.org\/10.3171\/2016.8.JNS16995","journal-title":"J Neurosurg"},{"key":"1849_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","volume":"26","author":"T Graillon","year":"2020","unstructured":"Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyriere H, Basset N, Autran D, Roche C, Kalamarides M, Roche PH, Fuentes S, Tabouret E, Barrie M, Cohen A, Honore S, Boucekine M, Baumstarck K, Figarella-Branger D, Barlier A, Dufour H, Chinot OL, Graillon T, Sanson M, Peyre M, Peyri\u00e8re H, Autran D, Kalamarides M, Roche P-H, Fuentes S, Tabouret E, Barrie M, Campello C, Idbaih A, Boucekine M, Figarella-Branger D, Chinot OL (2020) Everolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial. Clin Cancer Res 26:552\u2013557. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2109","journal-title":"Clin Cancer Res"},{"key":"1849_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.cdd.4401939","volume":"14","author":"J Guillermet-Guibert","year":"2007","unstructured":"Guillermet-Guibert J, Saint-Laurent N, Davenne L, Rochaix P, Cuvillier O, Culler MD, Pradayrol L, Buscail L, Susini C, Bousquet C (2007) Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways. Cell Death Differ 14:197\u2013208. https:\/\/doi.org\/10.1038\/sj.cdd.4401939","journal-title":"Cell Death Differ"},{"key":"1849_CR18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Falck-Ytter Y, Jaeschke R, Vist G, Akl EA, Post PN, Norris S, Meerpohl J, Shukla VK, Nasser M, Sch\u00fcnemann HJ (2011) GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness. J Clin Epidemiol 64:1303\u20131310. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.04.014","journal-title":"J Clin Epidemiol"},{"key":"1849_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW, Atkins D, Meerpohl J, Sch\u00fcnemann HJ (2011) GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias). J Clin Epidemiol 64:407\u2013415. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.017","journal-title":"J Clin Epidemiol"},{"key":"1849_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"key":"1849_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-021-05025-5","author":"J Haslund-Vinding","year":"2021","unstructured":"Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, Fugleholm K, Mirian C, Maier AD, Santarius T, Rom Poulsen F, Meling T, Bartek JJ, F\u00f6rander P, Larsen VA, Kristensen BW, Scheie D, Law I, Ziebell M, Mathiesen T (2021) Proposal of a new grading system for meningioma resection: the Copenhagen Protocol. Acta Neurochir (Wien). https:\/\/doi.org\/10.1007\/s00701-021-05025-5","journal-title":"Acta Neurochir (Wien)"},{"key":"1849_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0950-351x(96)80362-4","volume":"10","author":"LJ Hofland","year":"1996","unstructured":"Hofland LJ, Lamberts SW (1996) Somatostatin receptors and disease: role of receptor subtypes. Baillieres Clin Endocrinol Metab 10:163\u2013176. https:\/\/doi.org\/10.1016\/s0950-351x(96)80362-4","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"1849_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.00373","volume":"11","author":"M Hrachova","year":"2020","unstructured":"Hrachova M, Nguyen ENT, Fu BD, Dandekar MJ, Kong XT, Cadena G, Hsu FPK, Billimek J, Taylor TH, Bota DA (2020) A retrospective interventional cohort study to assess the safety and efficacy of sandostatin LAR for treatment of recurrent and\/or refractory meningiomas. Front Neurol 11:1\u201311. https:\/\/doi.org\/10.3389\/fneur.2020.00373","journal-title":"Front Neurol"},{"key":"1849_CR24","doi-asserted-by":"publisher","unstructured":"Jaffrain-Rea ML, Minniti G, Santoro A, Bastianello S, Tamburrano G, Gulino A, Cantore G (1998) Visual improvement during octreotide therapy in a case of episellar meningioma. Clin Neurol Neurosurg 100(1):40\u20133. https:\/\/doi.org\/10.1016\/S0303-8467(97)00110-8","DOI":"10.1016\/S0303-8467(97)00110-8"},{"key":"1849_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1158\/1078-0432.CCR-13-2103","volume":"20","author":"DL Jardim","year":"2014","unstructured":"Jardim DL, Hess KR, Lorusso P, Kurzrock R, Hong DS (2014) Predictive value of phase I trials for safety in later trials and final approved dose: analysis of 61 approved cancer drugs. Clin Cancer Res 20:281\u2013288. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2103","journal-title":"Clin Cancer Res"},{"key":"1849_CR26","doi-asserted-by":"publisher","unstructured":"Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W, Buckner JC (2011) Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. Neuro Oncol 13(5):530\u20135. https:\/\/doi.org\/10.1093\/neuonc\/nor044","DOI":"10.1093\/neuonc\/nor044"},{"key":"1849_CR27","doi-asserted-by":"publisher","unstructured":"Lamszus K, Lengler U, Schmidt NO, Stavrou D, Erg\u00fcn S, Westphal M (2000) Vascular endothelial growth factor, hepatocyte growth factor\/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 46(4):938\u201347. https:\/\/doi.org\/10.1097\/00006123-200004000-00033","DOI":"10.1097\/00006123-200004000-00033"},{"key":"1849_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/neuonc\/not330","volume":"16","author":"T Kaley","year":"2014","unstructured":"Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J, Rogers L, Schiff D, Vogelbaum M, Weber D, Wen P (2014) Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro Oncol 16:829\u2013840. https:\/\/doi.org\/10.1093\/neuonc\/not330","journal-title":"Neuro Oncol"},{"key":"1849_CR29","doi-asserted-by":"publisher","unstructured":"Kyriakakis N, Seejore K, Hanafy A, Murray RD (2020) Management of persistent acromegaly following primary therapy: The current landscape in the UK. Endocrinol Diabetes Metab 3(3)e00158. https:\/\/doi.org\/10.1002\/edm2.158","DOI":"10.1002\/edm2.158"},{"key":"1849_CR30","doi-asserted-by":"publisher","first-page":"24448","DOI":"10.1074\/jbc.272.39.24448","volume":"272","author":"F Lopez","year":"1997","unstructured":"Lopez F, Est\u00e8ve JP, Buscail L, Delesque N, Saint-Laurent N, Th\u00e9veniau M, Nahmias C, Vaysse N, Susini C (1997) The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272:24448\u201324454. https:\/\/doi.org\/10.1074\/jbc.272.39.24448","journal-title":"J Biol Chem"},{"key":"1849_CR31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"1849_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12892","author":"AD Maier","year":"2020","unstructured":"Maier AD, Stenman A, Svahn F, Mirian C, Bartek JJ, Juhler M, Zedenius J, Broholm H, Mathiesen T (2020) TERT promoter mutations in primary and secondary WHO grade III meningioma. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12892","journal-title":"Brain Pathol"},{"issue":"4","key":"1849_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","volume":"91","author":"C Mirian","year":"2020","unstructured":"Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, M\u00f8ller Pedersen M, Law I, Broholm H, Cahill DP, Brastianos P, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Mathiesen T (2020) Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. J Neurol Neurosurg Psychiatry 91(4):378\u2013387. https:\/\/doi.org\/10.1136\/jnnp-2019-322257","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1849_CR34","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.249607","author":"C Mirian","year":"2020","unstructured":"Mirian C, Duun-Henriksen AK, Maier AD, Pedersen MM, Jensen LR, Bashir A, Graillon T, Hrachova M, Bota D, van Essen M, Spanjol P, Kreis C, Law I, Broholm H, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Walter MA, Mathiesen T (2020) Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: an individual patient data meta-analysis. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.120.249607","journal-title":"J Nucl Med"},{"key":"1849_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12773","author":"C Mirian","year":"2021","unstructured":"Mirian C, Grell K, Juratli TA, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Jensen LR, Schackert G, Broholm H, Scheie D, Cahill DP, Brastianos PK, Skj\u00f8th-Rasmussen J, Fugleholm K, Ziebell M, Munch TN, Kristensen BW, Mathiesen T (2021) Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12773","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1849_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa226","author":"C Mirian","year":"2020","unstructured":"Mirian C, Skyrman S, Bartek J, Jensen LR, Kihlstr\u00f6m L, F\u00f6rander P, Orrego A, Mathiesen T (2020) The Ki-67 proliferation index as a marker of time to recurrence in intracranial meningioma. Neurosurgery. https:\/\/doi.org\/10.1093\/neuros\/nyaa226","journal-title":"Neurosurgery"},{"key":"1849_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S, Corona RI, Liu LY, Chen CY, Chakravarthy A, Wei Q, Mehani B, Suppiah S, Gao A, Workewych AM, Tabatabai G, Boutros PC, Bader GD, de Carvalho DD, Kislinger T, Aldape K, Zadeh G (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597:119\u2013125. https:\/\/doi.org\/10.1038\/s41586-021-03850-3","journal-title":"Nature"},{"key":"1849_CR38","unstructured":"National Cancer Institute (2006) Common terminology criteria for adverse events v3.0 (CTCAE).\u00a0https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf"},{"key":"1849_CR39","unstructured":"National Cancer Institute (2009) Common terminology criteria for adverse events v4.0 (CTCAE)\u00a0NIH Publ. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/Archive\/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf"},{"key":"1849_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1212\/WNL.0000000000001153","volume":"84","author":"AD Norden","year":"2015","unstructured":"Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY (2015) Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma. Neurology 84:280\u2013286. https:\/\/doi.org\/10.1212\/WNL.0000000000001153","journal-title":"Neurology"},{"key":"1849_CR41","doi-asserted-by":"publisher","first-page":"R551","DOI":"10.1530\/ERC-16-0151","volume":"23","author":"K \u00d6berg","year":"2016","unstructured":"\u00d6berg K, Lamberts SWJ (2016) Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future. Endocr Relat Cancer 23:R551\u2013R566. https:\/\/doi.org\/10.1530\/ERC-16-0151","journal-title":"Endocr Relat Cancer"},{"key":"1849_CR42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1159\/000448212","volume":"9","author":"A Ortol\u00e1 Buigues","year":"2016","unstructured":"Ortol\u00e1 Buigues A, Crespo Hern\u00e1ndez I, Jorquera Moya M, D\u00edaz P\u00e9rez J\u00c1 (2016) Unresectable recurrent multiple meningioma: a case report with radiological response to somatostatin analogues. Case Rep Oncol 9:520\u2013525. https:\/\/doi.org\/10.1159\/000448212","journal-title":"Case Rep Oncol"},{"key":"1849_CR43","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro Oncol 17:iv1\u2013iv62. https:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro Oncol"},{"key":"1849_CR44","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/sj.cdd.4401865","volume":"13","author":"S Papa","year":"2006","unstructured":"Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR, Dean K, Franzoso G (2006) The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ 13:712\u2013729. https:\/\/doi.org\/10.1038\/sj.cdd.4401865","journal-title":"Cell Death Differ"},{"key":"1849_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.02.002","author":"S Pyronnet","year":"2008","unstructured":"Pyronnet S, Bousquet C, Najib S, Azar R, Laklai H, Susini C (2008) Antitumor effects of somatostatin. Mol Cell Endocrinol. https:\/\/doi.org\/10.1016\/j.mce.2008.02.002","journal-title":"Mol Cell Endocrinol"},{"key":"1849_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3171\/2015.1.JNS142260","volume":"124","author":"R Rammo","year":"2016","unstructured":"Rammo R, Rock A, Transou A, Raghunathan A, Rock J (2016) Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease. J Neurosurg 124:496\u2013500. https:\/\/doi.org\/10.3171\/2015.1.JNS142260","journal-title":"J Neurosurg"},{"key":"1849_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","volume":"125","author":"DE Reuss","year":"2013","unstructured":"Reuss DE, Piro RM, Jones DTW, Simon M, Ketter R, Kool M, Becker A, Sahm F, Pusch S, Meyer J, Hagenlocher C, Schweizer L, Capper D, Kickingereder P, Mucha J, Koelsche C, J\u00e4ger N, Santarius T, Tarpey PS, Stephens PJ, Andrew Futreal P, Wellenreuther R, Kraus J, Lenartz D, Herold-Mende C, Hartmann C, Mawrin C, Giese N, Eils R, Collins VP, K\u00f6nig R, Wiestler OD, Pfister SM, von Deimling A (2013) Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 125:351\u2013358. https:\/\/doi.org\/10.1007\/s00401-013-1093-x","journal-title":"Acta Neuropathol"},{"key":"1849_CR48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.8510","author":"A Rinke","year":"2009","unstructured":"Rinke A, M\u00fcller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bl\u00e4ker M, Harder J, Arnold C, Gress T, Arnold R (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2009.22.8510","journal-title":"J Clin Oncol"},{"key":"1849_CR49","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0140-6736(89)92465-3","volume":"333","author":"MW R\u00fcnzi","year":"1989","unstructured":"R\u00fcnzi MW, Jaspers C, Windeck R, Benker G, Mehdorn HM, Reinhardt V, Reinwein D (1989) Successful treatment of meningioma with octreotide. Lancet 333:1074. https:\/\/doi.org\/10.1016\/S0140-6736(89)92465-3","journal-title":"Lancet"},{"key":"1849_CR50","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D, Sturm D, Wirsching H-G, Berghoff AS, Baumgarten P, Kratz A, Huang K, Wefers AK, Hovestadt V, Sill M, Ellis HP, Kurian KM, Okuducu AF, Jungk C, Drueschler K, Schick M, Bewerunge-Hudler M, Mawrin C, Seiz-Rosenhagen M, Ketter R, Simon M, Westphal M, Lamszus K, Becker A, Koch A, Schittenhelm J, Rushing EJ, Collins VP, Brehmer S, Chavez L, Platten M, Hanggi D, Unterberg A, Paulus W, Wick W, Pfister SM, Mittelbronn M, Preusser M, Herold-Mende C, Weller M, von Deimling A (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"1849_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.clineuro.2012.07.021","volume":"115","author":"SR Schreglmann","year":"2013","unstructured":"Schreglmann SR, Jel\u010di\u0107 I, Taegtmeyer AB, Linnebank M, Weller M (2013) Multifocal CNS demyelination after octreotide treatment for metastatic meningioma. Clin Neurol Neurosurg 115:817\u2013819. https:\/\/doi.org\/10.1016\/j.clineuro.2012.07.021","journal-title":"Clin Neurol Neurosurg"},{"key":"1849_CR52","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1042\/0300-5127:0290684","volume":"29","author":"M Schuler","year":"2001","unstructured":"Schuler M, Green DR (2001) Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29:684\u2013688. https:\/\/doi.org\/10.1042\/0300-5127:0290684","journal-title":"Biochem Soc Trans"},{"key":"1849_CR53","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2011.1.FOCUS111","volume":"30","author":"C Schulz","year":"2011","unstructured":"Schulz C, Ulm B, Kunz U, Mathieu R, Kunz U, Mauer UM (2011) Treatment of unresectable skull base meningiomas with somatostatin analogs. Neurosurg Focus 30:E11. https:\/\/doi.org\/10.3171\/2011.1.FOCUS111","journal-title":"Neurosurg Focus"},{"key":"1849_CR54","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/neuonc\/now060","volume":"18","author":"K Seystahl","year":"2016","unstructured":"Seystahl K, Stoecklein V, Schuller U, Rushing E, Nicolas G, Schafer N, Ilhan H, Pangalu A, Weller M, Tonn J-C, Sommerauer M, Albert NL (2016) Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE\/-TOC uptake. Neuro Oncol 18:1538\u20131547. https:\/\/doi.org\/10.1093\/neuonc\/now060","journal-title":"Neuro Oncol"},{"key":"1849_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2006.03.194","author":"A Shimatsu","year":"2006","unstructured":"Shimatsu A, Nakakuki T, Kimura T, Hagiwara H, Usui T, Nagata D, Tagami T, Naruse M, Tsukahara T (2006) Meningioma in an acromegalic patient treated with long-term octreotide therapy. Front Neuroendocrinol. https:\/\/doi.org\/10.1016\/j.yfrne.2006.03.194","journal-title":"Front Neuroendocrinol"},{"key":"1849_CR56","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, Neidert MC, Wirsching H-G, Mawrin C, Ketter R, Paulus W, Reifenberger G, Lamszus K, Westphal M, Etminan N, Ratliff M, Herold-Mende C, Pfister SM, Jones DTW, Weller M, Harter PN, Wick W, Preusser M, von Deimling A, Sahm F (2020) CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140:409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w","journal-title":"Acta Neuropathol"},{"key":"1849_CR57","doi-asserted-by":"publisher","unstructured":"Sim\u00f3 M, Argyriou AA, Maci\u00e0 M, Plans G, Maj\u00f3s C, Vidal N, Gil M, Bruna J (2014) Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy. Cancer Chemother Pharmacol 73(5):919\u201323. https:\/\/doi.org\/10.1007\/s00280-014-2422-z","DOI":"10.1007\/s00280-014-2422-z"},{"key":"1849_CR58","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan A-W, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"1849_CR59","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF (2015) Preferred Reporting Items for Systematic Review and Meta-analyses of Individual Participant Data: the PRISMA-IPD statement. JAMA 313:1657\u20131665. https:\/\/doi.org\/10.1001\/jama.2015.3656","journal-title":"JAMA"},{"issue":"12","key":"1849_CR60","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3390\/ijms20123049","volume":"20","author":"AK Stueven","year":"2019","unstructured":"Stueven AK, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F, Wiedenmann B, Roderburg C, Jann H (2019) Somatostatin analogues in the treatment of neuroendocrine tumors: past, present and future. Int J Mol Sci 20(12):3049. https:\/\/doi.org\/10.3390\/ijms20123049","journal-title":"Int J Mol Sci"},{"key":"1849_CR61","doi-asserted-by":"publisher","first-page":"29549","DOI":"10.1074\/jbc.274.41.29549","volume":"274","author":"M Thangaraju","year":"1999","unstructured":"Thangaraju M, Sharma K, Leber B, Andrews DW, Shen SH, Srikant CB (1999) Regulation of acidification and apoptosis by SHP-1 and Bcl-2. J Biol Chem 274:29549\u201329557. https:\/\/doi.org\/10.1074\/jbc.274.41.29549","journal-title":"J Biol Chem"},{"key":"1849_CR62","doi-asserted-by":"publisher","DOI":"10.1159\/000289569","author":"K Villaume","year":"2010","unstructured":"Villaume K, Blanc M, Gouysse G, Walter T, Couderc C, Nejjari M, Vercherat C, Cordier-Bussat M, Roche C, Scoazec JY (2010) VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K\/AKT\/mTOR pathway. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000289569","journal-title":"Neuroendocrinology"},{"key":"1849_CR63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nrd1255","volume":"2","author":"G Weckbecker","year":"2003","unstructured":"Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999\u20131017. https:\/\/doi.org\/10.1038\/nrd1255","journal-title":"Nat Rev Drug Discov"},{"key":"1849_CR64","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","volume":"23","author":"MW Youngblood","year":"2021","unstructured":"Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D, Montejo JD, Zhao A, Sheth A, Tyrtova E, \u00d6zduman K, Iacoangeli F, Peyre M, Boetto J, Pease M, Av\u015far T, Huttner A, Bilguvar K, Kilic T, Pamir MN, Amankulor N, Kalamarides M, Erson-Omay EZ, G\u00fcnel M, Moliterno J (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol 23:783\u2013794. https:\/\/doi.org\/10.1093\/neuonc\/noaa226","journal-title":"Neuro Oncol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-022-01849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-022-01849-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-022-01849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:35:01Z","timestamp":1663763701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-022-01849-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1849"],"URL":"https:\/\/doi.org\/10.1007\/s10143-022-01849-6","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Included data was untraceable, anonymized patient data that already has been published previously, thus not requiring Institutional Review Board approval by Danish law.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}